- Home
- SUZ vs BAX Comparison
SUZ vs BAX Comparison
Compare SUZ & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SUZ | BAX |
|---|---|---|
| Founded | 1924 | 1931 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Paper | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.8B | 10.0B |
| IPO Year | 2002 | 1994 |
Fundamental Metrics
Financial Performance| Metric | SUZ | BAX |
|---|---|---|
| Price | $8.30 | $19.53 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $21.00 |
| AVG Volume (30 Days) | 3.3M | ★ 6.4M |
| Earning Date | 05-11-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.15% | 0.24% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $11,244,000,000.00 |
| Revenue This Year | $13.28 | $1.96 |
| Revenue Next Year | $13.57 | $2.22 |
| P/E Ratio | $5.58 | ★ N/A |
| Revenue Growth | N/A | ★ 5.72 |
| 52 Week Low | $7.92 | $15.73 |
| 52 Week High | $11.54 | $31.76 |
Technical Indicators
Market Signals| Indicator | SUZ | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 46.76 | 52.08 |
| Support Level | $8.11 | $18.95 |
| Resistance Level | $9.66 | $19.90 |
| Average True Range (ATR) | 0.16 | 0.67 |
| MACD | 0.07 | 0.04 |
| Stochastic Oscillator | 55.56 | 42.25 |
Price Performance
Historical ComparisonAbout SUZ Suzano S.A.
Suzano SA produces and sells pulp and a variety of paper products. The company organizes itself into two segments based on product type: Pulp and Paper. The Pulp segment generates the majority of revenue. The firm's product portfolio includes printing and writing paper, paperboard, diapers, and sanitary napkins. The company owns forest land and plants in Brazil, where it harvests timber and turns the timber into pulp and paper in its plants.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.